DaRT seeds clinical trials

A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

This study looks at a new radiation treatment, Alpha DaRT224, for a type of skin cancer called squamous cell carcinoma that has come back. It aims to see how well it shrinks tumours and how safe it is for patients who don’t have other good treatment options.